The musician-turned-biotech-founder waiting to fundraise
Grammy-nominated musician Aloe Blacc discovered that personal funding cannot navigate the regulatory and commercialization barriers of biotech drug development. He's now bootstrapping a pancreatic cancer drug platform after realizing philanthropy can finance research but not clinical trials or regulatory approval. His journey reveals a critical gap for biotech founders: capital is abundant, but regulatory expertise is the limiting factor.See more


